Literature DB >> 28214208

Reduced immunohistochemical expression of adhesion molecules in vitiligo skin biopsies.

Adriane Reichert Faria1, Juliana Elizabeth Jung2, Caio César Silva de Castro3, Lucia de Noronha4.   

Abstract

Because defects in adhesion impairment seem to be involved in the etiopathogenesis of vitiligo, this study aimed to compare the immunohistochemical expression of several adhesion molecules in the epidermis of vitiligo and non lesional vitiligo skin. Sixty-six specimens of lesional and non lesional skin from 33 volunteers with vitiligo were evaluated by immunohistochemistry using anti-beta-catenin, anti-E-cadherin, anti-laminin, anti-beta1 integrin, anti-collagen IV, anti-ICAM-1 and anti-VCAM-1 antibodies. Biopsies of vitiligo skin demonstrated a significant reduction in the expression of laminin and integrin. The average value of the immunohistochemically positive reaction area of the vitiligo specimens was 3053.2μm2, compared with the observed value of 3431.8μm2 in non vitiligo skin (p=0.003) for laminin. The immuno-positive area was 7174.6μm2 (vitiligo) and 8966.7μm2 (non lesional skin) for integrin (p=0.042). A reduction in ICAM-1 and VCAM-1 expression in the basal layer of the epidermis in vitiligo samples was also observed (p=0.001 and p<0.001, respectively). However, no significant differences were observed with respect to the expression of beta-catenin, E-cadherin, and collagen IV between vitiligo and non lesional skin. Our results suggest that an impairment in adhesion exists in vitiligo skin, which is supported by the diminished immunohistochemical expression of laminin, beta1 integrin, ICAM-1 and VCAM-1.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adhesion; Immunohistochemistry; Paraffin- embedded; Skin biopsy; Vitiligo

Mesh:

Substances:

Year:  2016        PMID: 28214208     DOI: 10.1016/j.prp.2016.12.019

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

Review 1.  Current insight into the roles of microRNA in vitiligo.

Authors:  Shili Yan; Jingpei Shi; Dongjie Sun; Lechun Lyu
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

Review 2.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

Review 3.  Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.

Authors:  Paolo Custurone; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Domenica Altavilla; Alessandra Bitto; Giovanni Pallio; Francesco Squadrito; Mario Vaccaro
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

4.  Identification of the Role of Wnt/β-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo.

Authors:  Si-Jia Zhao; Hong Jia; Xiu-Lian Xu; Wen-Bo Bu; Qian Zhang; Xi Chen; Juan Ji; Jian-Fang Sun
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-09-01

Review 5.  Integrin Regulated Autoimmune Disorders: Understanding the Role of Mechanical Force in Autoimmunity.

Authors:  Souradeep Banerjee; Ritika Nara; Soham Chakraborty; Debojyoti Chowdhury; Shubhasis Haldar
Journal:  Front Cell Dev Biol       Date:  2022-03-18

6.  Identification and Validation of Autophagy-Related Genes in Vitiligo.

Authors:  Yiwen Yang; Xiuyi Wu; Xiaoli Lu; Chen Wang; Leihong Xiang; Chengfeng Zhang
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

7.  A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Kang-Bai-Ling for Treatment of Vitiligo.

Authors:  Manyuan Xu; Jianxin Shi; Zhongsheng Min; Hongliu Zhu; Weiguo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-03       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.